National Health Investors, Inc. (NYSE:NHI) Receives $83.86 Consensus Price Target from Brokerages

National Health Investors, Inc. (NYSE:NHI) has earned an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $83.8571.

A number of research firms have recently commented on NHI. BMO Capital Markets cut their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Truist Financial cut their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th.

Insider Activity at National Health Investors

In other news, CEO D. Eric Mendelsohn purchased 1,500 shares of National Health Investors stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors during the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC lifted its stake in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares during the period. Garton & Associates Financial Advisors LLC bought a new position in National Health Investors during the 4th quarter valued at about $33,000. Allworth Financial LP bought a new position in National Health Investors during the 2nd quarter valued at about $42,000. Finally, Key Capital Management INC bought a new stake in shares of National Health Investors in the fourth quarter worth approximately $47,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Performance

Shares of NHI opened at $73.91 on Friday. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The stock has a market cap of $3.63 billion, a P/E ratio of 21.36, a P/E/G ratio of 3.40 and a beta of 0.51. The business’s 50 day moving average price is $75.45 and its 200-day moving average price is $79.13. National Health Investors has a 52 week low of $67.94 and a 52 week high of $91.38.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period last year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts anticipate that National Health Investors will post 4.77 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. National Health Investors’s dividend payout ratio is presently 108.67%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.